Warnex is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical sector.

Warnex Bioanalytical Services conducts bioavailability and bioequivalence studies for clinical trials, and performs contract R&D for clients in the pharmaceutical and biotechnology industries.

Warnex was founded on and remains committed to a business philosophy that reduces risk while building long-term shareholder value.

The Company’s shares are traded on the TSX Venture Exchange (TSXV) under the symbol WNX.